Gladius Capital Management’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,361	Closed	-$25.3K	–	276
2023 Q1	$25.3K	Buy	+3,361	New	+$25.3K	﹤0.01%	227